2,769
Views
18
CrossRef citations to date
0
Altmetric
Article

Comparison of thermal ablation and routine surgery for the treatment of papillary thyroid microcarcinoma: a systematic review and Meta-analysis

, , , ORCID Icon, , , , , , , & show all
Pages 913-924 | Received 24 Apr 2020, Accepted 28 May 2020, Published online: 28 Jul 2020

References

  • Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164(6):658–661.
  • Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.,
  • Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008 ;144(6):980–987. discussion 987-988.
  • Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322.
  • Mauri G, Sconfienza LM. Image-guided thermal ablation might be a way to compensate for image deriving cancer overdiagnosis. Int J Hyperthermia. 2017;33(4):489–490.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
  • Kwon H, Oh H-S, Kim M, et al. Active surveillance for patients with papillary thyroid microcarcinoma: a single center's experience in Korea. J Clin Endocrinol Metab. 2017;102(6):1917–1925.
  • Jeong SY, Baek JH, Choi YJ, et al. Ethanol and thermal ablation for malignant thyroid tumours. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. Int J Hyperthermia. 2017;33(8):938–945.
  • Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75(3):714–720.
  • Baek JH, Kim YS, Sung JY, et al. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol. 2011;197(2):W331–336.
  • Guenette JP, Monchik JM, Dupuy DE. Image-guided ablation of postsurgical locoregional recurrence of biopsy-proven well-differentiated thyroid carcinoma. J Vasc Interv Radiol. 2013;24(5):672–679.
  • study Lcorptcbu-gpmaAp Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: a prospective study. Inter J Hyperthermia: Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2015;31:403–408.
  • Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. Int J Hyperthermia. 2014;30(2):150–157.
  • Mauri G, Cova L, Ierace T, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–1030.
  • Papini E, Bizzarri G, Bianchini A, et al. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab. 2013;98(1):E92–97.
  • Mauri G, Cova L, Tondolo T, et al. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metab. 2013;98(7):E1203–1207.
  • Lim HK, Baek JH, Lee JH, Kim WB, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015;25(1):163–170.
  • Bernardi S, Dobrinja C, Fabris B, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.
  • Wells G. 2001. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. http://wwwohrica/programs/clinical_epidemiology/oxfordasp
  • Collaboration C 2011. Cochrane handbook for systematic reviews of interventions version 5.1. 0. Hoboken: John Wiley & Sons.
  • Weitian C, Yi W, Ning Z. Ultrasonic guided microwave ablation in the treatment of thyroid papillary carcinoma and endoscopic surgical resection. Chinese Computed Medical Imaging. 2018;24:254–257.
  • Li J, Liu Y, Liu J, et al. Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North American Hyperthermia Group. 2018;34(5):653–659.
  • Zhang M, Tufano RP, Russell J, et al. Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up. Thyroid: official Journal of the American Thyroid Association. 2020;30(3):408–417.
  • Zhou W, Ni X, Xu S, et al. Ultrasound-guided laser ablation versus surgery for solitary papillary thyroid microcarcinoma: a retrospective study. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North American Hyperthermia Group. 2019;36(1):896–904.
  • Hangjun C. 2018. The efficacy, safety and economy of microwave ablation and surgical resection of thyroid micropapillary carcinoma were compared [硕士], Zhejiang University.
  • Fanghua M. 2018. A comparative study of percutaneous microwave ablation and surgical treatment of thyroid micropapillary carcinoma [硕士], Zhejiang University.
  • Li J, Liu Y, Liu J, et al. A comparative study of short-term efficacy and safety for thyroid micropapillary carcinoma patients after microwave ablation or surgery. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North American Hyperthermia Group. 2019;36(1):639–646.
  • Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid: official Journal of the American Thyroid Association. 2014;24(1):27–34.
  • Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34(6):1222–1231.
  • Yu X-M, Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Annals of Surgery. 2011;254(4):653–660.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
  • Choi H, Loyer EM, DuBrow RA, et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics: a review publication of the. Radiographics. 2001;21:S41–S54. Spec No:
  • Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging. 2001;26(4):345–360.
  • Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–451.
  • Mauri G, Gennaro N, Lee MK, et al. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperthermia. 2019;36(2):13–20.
  • Cova L, Mauri G, Tondolo T, et al. Percutaneous US-guided interstitial laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma following thyroidectomy and lymphadenectomy. Journal of Vascular and Interventional Radiology. 2012;23(8):1112.
  • Guang Y, Luo Y, Zhang Y, et al. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma. J Cancer Res Clin Oncol. 2017;143(8):1555–1562.
  • Guang Y, Luo YK, Zhang Y, et al. Ultrasound-guided Radiofrequency Ablation for Cervical Lymph Nodes Metastasis from Papillary Thyroid Carcinoma. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. 2018;40:67–71.
  • Zhou W, Chen Y, Zhang L, et al. Percutaneous microwave ablation of metastatic lymph nodes from papillary thyroid carcinoma: preliminary results. World J Surg. 2019;43(4):1029–1037.
  • Cho SJ, Baek JH, Chung SR, et al. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid: official Journal of the American Thyroid Association. 2019;29(12):1774–1783.,
  • Tong M, Li S, Li Y, et al. Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North American Hyperthermia Group. 2019;36(1):1277–1286.
  • Baek JH, Lee JH, Sung JY, et al.; Korean Society of Thyroid Radiology. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–342.
  • Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur Radiol. 2017;27(8):3128–3137.
  • Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–1250.
  • Wang J-F, Wu T, Hu K-P, et al. Complications following radiofrequency ablation of benign thyroid nodules: a systematic review. Chin Med J. 2017;130(11):1361–1370.
  • Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. Am J Neuroradiol. 2015;36(7):1321–1325.
  • Lang B-H, Wong CK, Tsang JS, et al. A systematic review and meta-analysis comparing surgically-related complications between robotic-assisted thyroidectomy and conventional open thyroidectomy. Ann Surg Oncol. 2014;21(3):850–861.
  • Ji-Hoon K, Hwan BJ, Kyung LH, Shin AH, et al. Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(6):1196.
  • Liu Z, Zeng W, Liu C, et al. Diagnostic accuracy of ultrasonographic features for lymph node metastasis in papillary thyroid microcarcinoma: a single-center retrospective study. World J Surg Oncol. 2017;15(1):32
  • Pedrazzini L, Baroli A, Marzoli L, et al. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Minerva Endocrinologica. 2013;38:269–279.
  • Wang W-H, Xu S-Y, Zhan W-W. Clinicopathologic factors and thyroid nodule sonographic features for predicting central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective study of 1204 patients. J Ultrasound Med: official Journal of the American Institute of Ultrasound in Medicine. 2016;35(11):2475–2481.
  • Takaki H, Cornelis F, Kako Y, et al. Thermal ablation and immunomodulation: from preclinical experiments to clinical trials. Diagn Interv Imaging. 98(9):651–659.
  • Kim H, Park BK, Kim CK. Kim CK spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma. Korean J Radiol. 2008;9(5):470–472.
  • Rao P, Escudier B, Baere T. Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Intervent Radiol. 2011;34(2):424–430.
  • Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review. Thyroid. 2018;28(9):1134–1142.
  • Gu Y, Feng C, Liu T, et al. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer. PLoS ONE. 2018;13(12):e0209338.
  • Gong Y, Yang J, Wu W, et al. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer. PLoS ONE. 2018;13(5):e0197007.
  • Mauri G, Pacella CM, Papini E, et al. Image-Guided Thyroid Ablation: Proposal for Standardization of Terminology and Reporting Criteria. Thyroid. 2019;29(5):611–618.